Register your email address for SimuGen updates
 

  • About Us
    • Overview
    • Management
    • Partnerships
    • Mission Statement
    • Investors
    • Careers
  • News & Events
  • Our Technology
    • Overview
    • Benefits
    • Product Launch
  • Support
    • Education Resources
    • Publications
    • Webinars
  • Downloads
  • Contact Us

Please download Flash player here.

SimuGen is a drug discovery pharmacogenomics company focused on predicting human safety earlier.


Seamlessly combine SimuGen's groundbreaking predictive models on your human in vitro data with your current ADMET workflow. Shift from hazard identification to true risk assessment for a wide spectrum of toxicities from day one.

Overview Using best practice in human cell culture and SimuGen's...

Benefits Easy to integrate with your current ADME workflows...

Product Launch SimuGen’s flagship product is due for launch early 2010.

CPGR and SimuGen to join forces in order to advance toxicity testing

SimuGen raises Venture Capital and Grant funding

SimuGen announces the appointment of Dr Brian O’Keeffe as CEO

Predictive Toxicology. 24-25 Feb 2010, London (UK)

China R&D Summit. 5-8 Apr 2010, Shanghai (China)

ADMET Europe. 8-9 Apr 2010, Munich (Germany)

BIO International Convention. 3-6 May 2010, Chicago (USA)

© 2009 SimuGen Asia.